Anders Berkenstam
Founder at Axcentua Pharmaceuticals AB
Profile
Anders Berkenstam is the founder of Axcentua Pharmaceuticals AB, which was founded in 2007.
He holds the title of Director & Chief Scientific Officer at the company.
Dr. Berkenstam also worked as an Associate Professor at Karolinska Institutet.
He obtained a doctorate degree from Karolinska Institutet.
Anders Berkenstam active positions
| Companies | Position | Start |
|---|---|---|
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Founder | 17/09/2009 |
Former positions of Anders Berkenstam
| Companies | Position | End |
|---|---|---|
| Karolinska Institutet | Corporate Officer/Principal | - |
Training of Anders Berkenstam
| Karolinska Institutet | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Anders Berkenstam
